| Heading: |
Brain: Tumours |
| Question ID: |
1806180 |
| UIN: |
54628 |
| House: |
Commons |
| Date tabled: |
2025-05-30 |
| Asking Member ID: |
1409 |
| Asking Member display name: |
Mr Gregory Campbell
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Mr Gregory Campbell
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the funding available for the National Institute of Health Research's consortium application for the evaluation of treatments for brain tumours unti |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-06-05 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Research is crucial in tackling cancer, which is why the Department invests over £1.6 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 202... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |